FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target

Although a standardized approach to radiotherapy has been used to treat breast cancer, regardless of subtype (e.g., luminal, basal), recent clinical data suggest that radiation response may vary significantly among subtypes. We hypothesized that this clinical variability may be due, in part, to diff...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Radiat Res
Prif Awduron: Horton, Janet K., Siamakpour-Reihani, Sharareh, Lee, Chen-Ting, Zhou, Ying, Chen, Wei, Geradts, Joseph, Fels, Diane R., Hoang, Peter, Ashcraft, Kathleen A., Groth, Jeff, Kung, Hsiu-Ni, Dewhirst, Mark W., Chi, Jen-Tsan A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4671819/
https://ncbi.nlm.nih.gov/pubmed/26488758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR14089.1
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg